How to Buy Pharming Group Nv Stock
Pharming Group Nv
Pharming Group N. V. , a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally.
Pharming Group Nv stock last closed at $8.15, up 0.74% from the previous day, and has decreased 17.84% in one year. It has overperformed other stocks in the Biotechnology industry by 0.6 percentage points. Pharming Group Nv stock is currently +22.56% from its 52-week low of $6.65, and -26.38% from its 52-week high of $11.07.
There are currently 680.31M PHAR shares outstanding. The market value of PHAR is $554.45M. In the last 24 hours, 2847 PHAR shares were traded.
How to Buy Pharming Group Nv Stock
Wondering how to invest in Pharming Group Nv stock? Here's how.
- Decide where to buy Pharming Group Nv stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you choose where to buy Pharming Group Nv stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your investment account: Choose your method of payment and add your details.
- Analyze Pharming Group Nv stock: The Pharming Group Nv ticker symbol is PHAR. Is Pharming Group Nv stock a good investment? Should you buy shares of PHAR? How do PHAR's underlying business fundamentals look? Do top analysts think Pharming Group Nv is a good buy? Why has PHAR's stock price moved recently? (Hint: Our stock research tools can help you figure out if PHAR is a good stock to buy).
- Place your PHAR buy order: Decide if you will purchase PHAR shares at the current market price or use a limit order to buy PHAR stock at a particular price.
- Watch your PHAR position: Create a watchlist to important notifications about your new investment in Pharming Group Nv stock.
Step 1: Decide where to buy Pharming Group Nv stock
You will need an online brokerage account to access the NASDAQ market and buy PHAR stock.
Our preferred brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global markets: From Tech to Utilities, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've selected your brokerage, you'll need to fill out some personal details so you are able to invest in PHAR stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to open a new trading account.
- Send your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have finished signing up on the highest rated stock app, your next step is to transfer the money for your investment:
Watch the tutorial below for more details depositing money into your brokerage account.
Step 4: Analyze Pharming Group Nv stock
After you have chosen the best place to buy Pharming Group Nv stock, it's important to evaluate their stock before you buy, so you truly understand the risk and opportunity.
Overview of key PHAR info
Pharming Group Nv Due Diligence Checks
WallStreetZen was created to help part-time investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on PHAR's stock page.
What is the fair value of PHAR stock?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge PHAR's intrinsic value.
Using relative valuations ratios:
- PHAR may be undervalued based on its P/B ratio of 2.26x, relative to Biotechnology industry P/B ratio of 4.04x
You can do additional valuation research on PHAR's stock here.
PHAR Financials at a glance
Passed Financial Due Diligence Checks:
- PHAR profit margin has gone up from -4.3% to -4% in the past year.
- Total PHAR debt is lower than 5 years ago, relative to shareholder equity.
- PHAR has $186.55M in cash and short term investments. This is sufficient to cover its annual cash burn of $2.87M.
- PHAR has cash burn of 2872222. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the PHAR balance sheet.
- There are more short-term assets than long-term liabilities on the PHAR balance sheet.
Failed Financial Due Diligence Checks:
- PHAR has a relatively high debt to equity ratio of 0.81.
Is PHAR stock a Buy, Hold, or Sell, according to analysts?
Out of 3 sell side analysts who give forecasts on PHAR, the consensus analyst rating on Pharming Group Nv is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Pharming Group Nv stock forecast page.
Metrics for Advanced PHAR Traders
PHAR Earnings
Last year, PHAR revenue was $330.22M. Over the past 5 year, PHAR's revenue has increased by 7.79% per year. This was slower than the Biotechnology industry average of 44.31%.
Dive into PHAR's earnings and revenue performance here.
Are PHAR executives and large shareholders buying or selling the stock?
In the last 12 months, insiders at PHAR have not bought or sold any shares.
Research more about who owns PHAR shares here.
Can I get consistent income from PHAR stock?
No, Pharming Group Nv doesn't provide an income stream by paying out dividends.
PHAR Social Trading Data
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your PHAR buy order
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually the best for newer investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a specific price, use a limit order.
Click the Open Trade button and your broker will execute your order.
If you want more help with investing in stocks on eToro, watch the how to video below:
Step 6: Watch your PHAR position
Now that you own some PHAR shares, you'll want to stay up-to-date on your new investment.
Start a watchlist to track the most important metrics related to your PHAR stock.
PHAR Feed
How to Buy Stock in Pharming Group Nv
To reiterate, here are the 6 steps for buying Pharming Group Nv stock:
- Decide where to buy Pharming Group Nv stock
- Create your brokerage account
- Fund your investment account
- Analyze Pharming Group Nv stock
- Place your PHAR buy order
- Watch your PHAR position
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your new investment in Pharming Group Nv, create a watchlist today.
More "How To" Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.